Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Aug 8, 2016
Insider Transaction Report
Form 4
KAVANAGH SARAH B
Director
Transactions
- Award
Common Stock, no par value
2016-07-27+14,458→ 14,458 total
Footnotes (2)
- [F1]Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]Prorated annual grant of restricted stock units equal to $339,640. Pricing is based on the closing price of registrant common stock on the date of grant.